Cosmetic cross-reference

Ethylparaben

CAS 120-47-8

Ethylparaben (CAS 120-47-8) is a pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
14
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Ethylparaben
CAS Number
120-47-8
UNII
14255EXE39
InChIKey
NUVBSKCKDOMJSU-UHFFFAOYSA-N
ChEMBL ID
CHEMBL15841
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 14 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- GI50 99159.67113207548 nM 53 -
- AC50 27198.614705882355 nM 34 -
- Ki 7650 nM 6 -
- Potency 25871.2 nM 3 -
- EC50 20030 nM 2 -
- IC50 19976.309999999998 nM 1 -
Carbonic anhydrase 2
Enzyme
Ki 5.32 - Homo sapiens
Estrogen receptor
Nuclear hormone receptor
EC50 4.42 - Homo sapiens
Carbonic anhydrase 1
Enzyme
Ki 5.1 - Homo sapiens
Estrogen receptor beta
Nuclear hormone receptor
EC50 5.73 - Homo sapiens
Carbonic anhydrase 9
Enzyme
Ki 5.09 - Homo sapiens
Carbonic anhydrase 12
Enzyme
Ki 5.07 - Homo sapiens
Carbonic anhydrase 7
Enzyme
Ki 5.06 - Homo sapiens
Carbonic anhydrase 14
Enzyme
Ki 5.11 - Homo sapiens
SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
ETHYLPARABEN 1362892 SU MTHSPL
ethylparaben 1362892 SU MTHSPL
ethylparaben 1362892 SY RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Ethylparaben used for in pharmaceutical contexts?

Ethylparaben (CAS 120-47-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Ethylparaben?

No adverse-event association or SIDER side-effect rows are rendered for Ethylparaben in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Ethylparaben also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Ethylparaben with EU status "restricted".

What clinical phase is Ethylparaben in?

No phase 1-4 clinical development badge is rendered for Ethylparaben because the matched compound identifier rows do not contain a max-phase value.

What bioactivity targets are documented for Ethylparaben?

Ethylparaben has 14 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 2, Estrogen receptor, Carbonic anhydrase 1, Estrogen receptor beta, Carbonic anhydrase 9.